Read more at MarketWatch.
Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Date: |
Topics
-
Business - MarketWatch
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief ...13 minutes ago -
Business - MarketWatch
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy
The Phase 3 trial of apitegromab showed statistically significant improvement in motor function.Yesterday -
World - Financial Times
Samsung issues public apology after falling behind on AI
Chip division head says performance has not met expectations as memory maker’s latest earnings guidance disappoints12 hours ago -
World - Financial Times
Under the influence: exploring Carlsberg’s Copenhagen
The brewing giant’s architectural and cultural legacy is unmissable in the Danish capital — especially in the district where its story began10 hours ago -
Top stories - BBC News
China stock rally fizzles as stimulus news disappoints
Shares fell back after a news conference by economic planners gave little in the way of details.6 hours ago - China -
Business - MarketWatch
Mobileye’s stock is down 70% this year — and J.P. Morgan says it’s not done falling
Four of 30 analysts are now bearish on the self-driving-technology stock, and the latest one sees about 20% further downside.18 hours ago -
Business - MarketWatch
Qualcomm’s stock isn’t the AI play that it was expected to be, analyst says
Shares of Qualcomm Inc. took a hit Tuesday after KeyBanc Capital dropped its longtime buy call, saying the semiconductor maker hasn’t been benefiting as expected from the artificial-intelligence ...18 minutes ago -
Business - MarketWatch
‘DJT’ stock soars after Elon Musk joins Trump at Butler rally
The stock is on pace for its biggest gain since July 15, the first trading session after an assassination attempt against Donald Trump in Pennsylvania.22 hours ago - Elon Musk
More from MarketWatch
-
Business - MarketWatch
Retirees may not be getting their money’s worth from a financial adviser. How to know if it’s time to find a new one.
Advisers who excel in helping clients build their nest egg may be less skilled at addressing Social Security or drawdown strategies.7 minutes ago -
Business - MarketWatch
The next Social Security COLA increase won’t be enough to solve this crisis.
Millions of older adults already can’t afford housing, food or healthcare.8 minutes ago -
Business - MarketWatch
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief ...13 minutes ago -
Business - MarketWatch
Qualcomm’s stock isn’t the AI play that it was expected to be, analyst says
Shares of Qualcomm Inc. took a hit Tuesday after KeyBanc Capital dropped its longtime buy call, saying the semiconductor maker hasn’t been benefiting as expected from the artificial-intelligence ...18 minutes ago -
Business - MarketWatch
Brent falls below $80 on talk of Lebanon-Israel ceasefire
A rally in oil prices took a pause on Tuesday as militant group Hezbollah reportedly said it supports efforts by Lebanon toward a ceasefire with Israel, helping to ease tensions in the oil-rich ...30 minutes ago - Israel